ImmunoPrecise Partners with Eurofins Discovery
Learn more about our expanding network and enhanced preclinical capabilities.
Preclinical ServicesInnovation
Accelerated
In the News
Now Approved for French Tax Credit (CIR)
French companies who qualify can now receive a tax benefit
Learn More
Data Driven Discovery
Innovation drives antibody discovery. We deliver elusive antibodies in a short period of time, with high probability of succeeding to clinical trials.
Company
Our multi-national team has the experience and expertise to accelerate your project.
COVID-19
Our subsidiary Talem Therapeutics has developed a rich and diverse discovery portfolio of SARS-CoV-2 candidate antibodies yielding epitope and functional diversity.